ロード中...
Real-World Reductions in Oral Corticosteroid Use in the USA Following Mepolizumab Therapy for Severe Asthma
BACKGROUND: Patients with severe asthma often require oral corticosteroid (OCS) treatment. Clinical trials have demonstrated that mepolizumab can reduce OCS dependence, but real-world data are limited. OBJECTIVE: To evaluate the impact of mepolizumab on OCS use, asthma exacerbations, and asthma exac...
保存先:
| 出版年: | J Asthma Allergy |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751313/ https://ncbi.nlm.nih.gov/pubmed/33364788 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S275944 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|